{
    "title": "GlaxoSmithKline sees third quarter earnings beat forecasts thanks to strong demand for HIV drugs and flu vaccines",
    "url": "https://www.dailymail.co.uk/money/markets/article-3293587/GlaxoSmithKline-sees-quarter-earnings-beat-forecasts-thanks-strong-demand-HIV-drugs-flu-vaccines.html",
    "date": "2015-10-28",
    "keywords": [
        "cent",
        "share",
        "quarter",
        "group",
        "demand",
        "drugmaker",
        "prescription",
        "hiv",
        "business",
        "glaxos",
        "glaxosmithkline",
        "market",
        "flu",
        "report",
        "scrip",
        "executive",
        "road",
        "recovery",
        "revamp",
        "asset",
        "swap",
        "firm",
        "novartis",
        "exposure",
        "consumer",
        "healthcare",
        "portfolio",
        "overthecounter",
        "toothpaste",
        "improvement",
        "profitability",
        "gloom",
        "shire",
        "slide",
        "approval",
        "blood",
        "article",
        "respiratory",
        "medicine",
        "pricing",
        "pressure",
        "advair",
        "inhaler",
        "competition",
        "ftse",
        "index",
        "afternoon",
        "trade",
        "david",
        "morrison",
        "strategist",
        "spread",
        "co",
        "reaction",
        "stock",
        "aftermath",
        "newsbut",
        "sector",
        "profit",
        "corruption",
        "scandal",
        "chinahelal",
        "miah",
        "investment",
        "research",
        "analyst",
        "centre",
        "progress",
        "rd",
        "innovation",
        "performancewe",
        "buy",
        "risk",
        "income",
        "company",
        "value",
        "operating",
        "model",
        "result",
        "guidance",
        "remainder"
    ],
    "category": [
        "money",
        "markets"
    ]
}